e-learning
resources
London 2016
Wednesday, 07.09.2016
Airway pharmacology: drug targets and mode of action
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
WNT-4 regulates pro-inflammatory responses driven by epithelial-mesenchymal cross-talk
Anita I. R. Spanjer (Groningen, Netherlands), Anita I.R. Spanjer, Eline M. van Dijk, Jacobien A. Noordhoek, Corry-Anke Brandsma, Wim Timens, Dirkje S. Postma, Herman Meurs, Reinoud Gosens, Irene H. Heijink
Source:
International Congress 2016 – Airway pharmacology: drug targets and mode of action
Session:
Airway pharmacology: drug targets and mode of action
Session type:
Poster Discussion
Number:
5067
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anita I. R. Spanjer (Groningen, Netherlands), Anita I.R. Spanjer, Eline M. van Dijk, Jacobien A. Noordhoek, Corry-Anke Brandsma, Wim Timens, Dirkje S. Postma, Herman Meurs, Reinoud Gosens, Irene H. Heijink. WNT-4 regulates pro-inflammatory responses driven by epithelial-mesenchymal cross-talk. Eur Respir J 2016; 48: Suppl. 60, 5067
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling?
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
The AMPK-TSC1/2-mTOR signaling pathway regulates cigarette smoking-induced inflammation and apoptosis in airway epithelial cells
Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products
Year: 2015
Involvement of JNK in TNFα driven remodelling
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Alveolar macrophages activate STAT3 in epithelial cells via gp130 dependant steroid insensitive mechanism
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
PI3K and notch signal pathways coordinately regulate the activation and proliferation of T lymphocytes in asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
rHuKGF optimistically attenuates MAPK/ERK mediated cell proliferation pathway in emphysematous lungs
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Cigarette smoke impairs Sirt1 activity and promotes pro-inflammatory responses in bronchial epithelial cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B.
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Non-canonical WNT-5A signaling attenuates endogenous lung repair in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Nociceptin modulates the inflammatory immune microenvironment in a conventional murine model of asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Dysregulation of the “inflammatory reflex” with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD
Source: Eur Respir J, 51 (6) 1800806; 10.1183/13993003.00806-2018
Year: 2018
IL-4 induced changes in the Wnt signalling of bronchial epithelial cells
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Targeting the mTOR signaling pathway to inhibit lung cell senescence in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
The crucial role of the expression of negative regulator of gene transcription SOCS5 in asthma pathogenesis
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Inflammation induced conformational changes in Z alpha-1 antirypsin promotes lung Z-AT cell damage
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept